"Leukemia, Mast-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of systemic mastocytosis (MASTOCYTOSIS, SYSTEMIC) characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of >20% MAST CELLS, multi-organ failure and a short survival.
| Descriptor ID |
D007946
|
| MeSH Number(s) |
C04.557.337.440 C04.557.337.539.275.440 C04.557.450.565.465.750.500
|
| Concept/Terms |
Leukemia, Mast-Cell- Leukemia, Mast-Cell
- Leukemia, Mast Cell
- Leukemias, Mast-Cell
- Mast-Cell Leukemias
- Mast-Cell Leukemia
- Mast Cell Leukemia
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Mast-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Mast-Cell".
This graph shows the total number of publications written about "Leukemia, Mast-Cell" by people in this website by year, and whether "Leukemia, Mast-Cell" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Leukemia, Mast-Cell" by people in Profiles.
-
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv. 2020 03 24; 4(6):1038-1050.
-
Aleukemic mast cell leukemia associated with chronic myelomonocytic leukemia and chronic lymphocytic leukemia. Blood. 2017 11 09; 130(19):2150.
-
Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome. Leuk Res. 2017 08; 59:105-109.
-
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann Oncol. 2014 Sep; 25(9):1691-1700.
-
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur J Haematol. 2013 Feb; 90(2):89-98.